Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Mayinglong Pharmaceutical Group Co., LTD.

Market Cap 10.05B 1.48B 1.29B 1.19B 1.11B 2.08B 142B 2.12B 14.16B 5.48B 68.47B 5.57B 5.45B 238B P/E Ratio 2026 *
14.9x
P/E Ratio 2027 * 12.4x
Enterprise Value 10.05B 1.48B 1.29B 1.19B 1.11B 2.08B 142B 2.12B 14.16B 5.48B 68.47B 5.57B 5.45B 238B EV / Sales 2026 *
2.33x
EV / Sales 2027 * 2.11x
Free-Float
64.65%
Yield 2026 *
-
Yield 2027 * -
1 day-1.31%
Current month-3.60%
1 month-10.58%
3 months-11.50%
6 months-18.46%
Current year-16.71%
1 week 23.21
Extreme 23.21
24.3
1 month 23.09
Extreme 23.09
26.28
Current year 23.09
Extreme 23.09
29.22
1 year 23.09
Extreme 23.09
30.18
3 years 20.2
Extreme 20.2
31.46
5 years 17.99
Extreme 17.99
33.54
10 years 12.52
Extreme 12.52
33.54
Manager TitleAgeSince
Chief Executive Officer 48 2019-05-27
Director of Finance/CFO 49 2023-12-27
Corporate Officer/Principal 40 2021-08-18
Director TitleAgeSince
Chairman 64 2010-03-15
Director/Board Member 48 2019-05-27
Director/Board Member 40 2022-06-13
Change 5-day change 1-year change 3-year change Capi.($)
-1.31%0.00%-19.97%-20.05% 1.48B
+2.16%+3.17%+43.57%+160.28% 1,035B
-0.07%+4.45%+53.50%+48.95% 574B
-0.08%-0.08%+17.37%+62.66% 397B
+0.61%+0.77%+21.19%+15.95% 324B
+0.33%-1.70%+23.50%+15.15% 281B
+0.77%+3.63%+24.67%+34.59% 278B
+0.17%+3.75%-45.65%-48.41% 193B
+4.84%+2.45%+21.33%+61.85% 191B
+3.61%-2.56%+15.16%+61.12% 156B
Average +0.52%+1.23%+15.47%+39.21% 343.14B
Weighted average by Cap. +0.47%+2.39%+29.33%+72.84%

Financials

2026 *2027 *
Net sales 4.32B 637M 553M 510M 478M 892M 61.02B 911M 6.08B 2.35B 29.41B 2.39B 2.34B 102B 4.75B 702M 609M 561M 526M 983M 67.18B 1B 6.7B 2.59B 32.38B 2.63B 2.58B 113B
Net income 674M 99.47M 86.32M 79.57M 74.56M 139M 9.52B 142M 949M 367M 4.59B 373M 365M 15.96B 745M 110M 95.42M 87.95M 82.41M 154M 10.53B 157M 1.05B 406M 5.07B 413M 404M 17.65B
Net Debt - -
Logo Mayinglong Pharmaceutical Group Co., LTD.
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the production and sale of anorectal health products. The Company operates three segments. The Pharmaceutical Industry segment is mainly engaged in the development, production and sale of pharmaceuticals and health products. The Pharmaceutical Commerce segment is mainly engaged in the retail and wholesale of medical devices and pharmaceuticals. The Hospital Diagnosis and Treatment segment is mainly engaged in hospital medical services and management. The Company mainly conducts businesses within the domestic market.
Employees
2,544
Date Price Change Volume
26-06-11 23.32 ¥ -1.31% 3,070,599
26-06-10 23.63 ¥ +1.33% 2,887,942
26-06-09 23.32 ¥ -0.34% 2,901,650
26-06-08 23.40 ¥ -2.50% 4,321,409
26-06-05 24.00 ¥ +2.92% 4,434,751
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
23.32CNY
Average target price
36.25CNY
Spread / Average Target
+55.45%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600993 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!